 | • レポートコード：MRC-IM30420 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥369,852 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥665,852 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| IMARC社の調査レポートによると、世界の吸入用一酸化窒素市場規模は2021年に806.1百万ドルに達しました。今後、2027年には1,274.4百万ドルになり、2022年から2022年の間に年平均8.1％成長すると予測しています。本調査レポートでは、吸入用一酸化窒素の世界市場について調査・分析を行い、序論、調査範囲・手法、エグゼクティブサマリー、イントロダクション、用途別（新生児呼吸器治療、慢性閉塞性肺疾患（COPD）、急性呼吸窮迫症候群（ARDS）、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などを掲載しています。なお、企業情報には、Air Liquide S.A, Bellerophon Therapeutics, Beyond Air Inc., Linde plc, Mallinckrodt plc, Merck KGaA, Novoteris LLC, Nu-Med Plus and VERO Biotech LLC.などが含まれています。 ・序論 ・調査範囲・手法 ・エグゼクティブサマリー ・イントロダクション ・世界の吸入用一酸化窒素市場規模：用途別 - 新生児呼吸器治療用一酸化窒素の市場規模 - 慢性閉塞性肺疾患（COPD）の市場規模 - 急性呼吸窮迫症候群（ARDS）の市場規模 - その他用途の市場規模 ・世界の吸入用一酸化窒素市場規模：地域別 - 北米の吸入用一酸化窒素市場規模 - アジアの吸入用一酸化窒素市場規模 - 欧州の吸入用一酸化窒素市場規模 - 中南米の吸入用一酸化窒素市場規模 - 中東・アフリカの吸入用一酸化窒素市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global inhaled nitric oxide market size reached US$ 806.1 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,274.4 Million by 2027, exhibiting a growth rate (CAGR) of 8.1% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Inhaled nitric oxide (iNO) refers to a selective pulmonary vasodilator supervised by skilled physicians at tertiary neonatal intensive care units (NICUs). It assists in regulating vascular muscle tone and treating hypoxemic respiratory failure among newly born infants by improving ventilation-perfusion mismatch and reducing elevated pulmonary vascular resistance and hypertension. It also aids in improving oxygenation and decreasing the need for extracorporeal membrane oxygenation (ECMO). At present, there is a rise in the use of iNO therapy as a rescue agent for acute respiratory distress syndrome (ARDS) patients.
Inhaled Nitric Oxide Market Trends:
The increasing prevalence of respiratory and other subsequent diseases in newborns, such as persistent pulmonary hypertension and neonatal hypoxic respiratory failure (HRF), represents one of the primary factors significantly contributing to the market growth. Additionally, the rising geriatric population, which is relatively more prone to hypertension, atherosclerosis, peripheral artery disease, heart failure, and thrombosis, is supporting the growth of the market. Furthermore, iNO is gaining immense traction worldwide for treating chronic obstructive pulmonary diseases (COPD), asthma, and ARDS. Moreover, the outbreak of the highly contagious coronavirus disease (COVID-19) and an alarmingly increasing number of individuals getting infected on a global level are favorably influencing the market. Furthermore, iNO therapy is being used against coronavirus stains as it assists in improving ventilation/perfusion in patients with severe pneumonia. The market is also driven by the ongoing research and development (R&D) activities in the healthcare industry around the world to improve the overall patient experience.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global inhaled nitric oxide market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on application.
Breakup by Application:
Neonatal Respiratory Treatment
Chronic Obstructive Pulmonary Disease (COPD)
Acute Respiratory Distress Syndrome (ARDS)
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Air Liquide S.A, Bellerophon Therapeutics, Beyond Air Inc., Linde plc, Mallinckrodt plc, Merck KGaA, Novoteris LLC, Nu-Med Plus and VERO Biotech LLC.
Key Questions Answered in This Report:
How has the global inhaled nitric oxide market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global inhaled nitric oxide market?
What are the key regional markets?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global inhaled nitric oxide market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Inhaled Nitric Oxide Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Application
6.1 Neonatal Respiratory Treatment
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Chronic Obstructive Pulmonary Disease (COPD)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Acute Respiratory Distress Syndrome (ARDS)
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Region
7.1 North America
7.1.1 United States
7.1.1.1 Market Trends
7.1.1.2 Market Forecast
7.1.2 Canada
7.1.2.1 Market Trends
7.1.2.2 Market Forecast
7.2 Asia-Pacific
7.2.1 China
7.2.1.1 Market Trends
7.2.1.2 Market Forecast
7.2.2 Japan
7.2.2.1 Market Trends
7.2.2.2 Market Forecast
7.2.3 India
7.2.3.1 Market Trends
7.2.3.2 Market Forecast
7.2.4 South Korea
7.2.4.1 Market Trends
7.2.4.2 Market Forecast
7.2.5 Australia
7.2.5.1 Market Trends
7.2.5.2 Market Forecast
7.2.6 Indonesia
7.2.6.1 Market Trends
7.2.6.2 Market Forecast
7.2.7 Others
7.2.7.1 Market Trends
7.2.7.2 Market Forecast
7.3 Europe
7.3.1 Germany
7.3.1.1 Market Trends
7.3.1.2 Market Forecast
7.3.2 France
7.3.2.1 Market Trends
7.3.2.2 Market Forecast
7.3.3 United Kingdom
7.3.3.1 Market Trends
7.3.3.2 Market Forecast
7.3.4 Italy
7.3.4.1 Market Trends
7.3.4.2 Market Forecast
7.3.5 Spain
7.3.5.1 Market Trends
7.3.5.2 Market Forecast
7.3.6 Russia
7.3.6.1 Market Trends
7.3.6.2 Market Forecast
7.3.7 Others
7.3.7.1 Market Trends
7.3.7.2 Market Forecast
7.4 Latin America
7.4.1 Brazil
7.4.1.1 Market Trends
7.4.1.2 Market Forecast
7.4.2 Mexico
7.4.2.1 Market Trends
7.4.2.2 Market Forecast
7.4.3 Others
7.4.3.1 Market Trends
7.4.3.2 Market Forecast
7.5 Middle East and Africa
7.5.1 Market Trends
7.5.2 Market Breakup by Country
7.5.3 Market Forecast
8 SWOT Analysis
8.1 Overview
8.2 Strengths
8.3 Weaknesses
8.4 Opportunities
8.5 Threats
9 Value Chain Analysis
10 Porters Five Forces Analysis
10.1 Overview
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Degree of Competition
10.5 Threat of New Entrants
10.6 Threat of Substitutes
11 Price Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Key Players
12.3 Profiles of Key Players
12.3.1 Air Liquide S.A
12.3.1.1 Company Overview
12.3.1.2 Product Portfolio
12.3.1.3 Financials
12.3.1.4 SWOT Analysis
12.3.2 Bellerophon Therapeutics
12.3.2.1 Company Overview
12.3.2.2 Product Portfolio
12.3.2.3 Financials
12.3.3 Beyond Air Inc.
12.3.3.1 Company Overview
12.3.3.2 Product Portfolio
12.3.3.3 Financials
12.3.4 Linde plc
12.3.4.1 Company Overview
12.3.4.2 Product Portfolio
12.3.4.3 Financials
12.3.5 Mallinckrodt plc
12.3.5.1 Company Overview
12.3.5.2 Product Portfolio
12.3.5.3 Financials
12.3.6 Merck KGaA
12.3.6.1 Company Overview
12.3.6.2 Product Portfolio
12.3.6.3 Financials
12.3.6.4 SWOT Analysis
12.3.7 Novoteris LLC
12.3.7.1 Company Overview
12.3.7.2 Product Portfolio
12.3.8 Nu-Med Plus
12.3.8.1 Company Overview
12.3.8.2 Product Portfolio
12.3.8.3 Financials
12.3.9 VERO Biotech LLC
12.3.9.1 Company Overview
12.3.9.2 Product Portfolio
Figure 2: Global: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Inhaled Nitric Oxide Market: Breakup by Application (in %), 2021
Figure 5: Global: Inhaled Nitric Oxide Market: Breakup by Region (in %), 2021
Figure 6: Global: Inhaled Nitric Oxide (Neonatal Respiratory Treatment) Market: Sales Value (in Million US$), 2016 & 2021
Figure 7: Global: Inhaled Nitric Oxide (Neonatal Respiratory Treatment) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 8: Global: Inhaled Nitric Oxide (Chronic Obstructive Pulmonary Disease-COPD) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Inhaled Nitric Oxide (Chronic Obstructive Pulmonary Disease-COPD) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Inhaled Nitric Oxide (Acute Respiratory Distress Syndrome-ARDS) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Inhaled Nitric Oxide (Acute Respiratory Distress Syndrome-ARDS) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Inhaled Nitric Oxide (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Inhaled Nitric Oxide (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: North America: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: North America: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: United States: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: United States: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Canada: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Canada: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Asia-Pacific: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Asia-Pacific: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: China: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: China: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Japan: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Japan: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: India: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: India: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: South Korea: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: South Korea: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Australia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Australia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Indonesia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Indonesia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Europe: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Europe: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Germany: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Germany: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: France: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: France: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: United Kingdom: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: United Kingdom: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Italy: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Italy: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Spain: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Spain: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Russia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Russia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Latin America: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Latin America: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Brazil: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Brazil: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Mexico: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Mexico: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Middle East and Africa: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Middle East and Africa: Inhaled Nitric Oxide Market: Breakup by Country (in %), 2021
Figure 62: Middle East and Africa: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Global: Inhaled Nitric Oxide Industry: SWOT Analysis
Figure 64: Global: Inhaled Nitric Oxide Industry: Value Chain Analysis
Figure 65: Global: Inhaled Nitric Oxide Industry: Porter's Five Forces Analysis